跳至主要内容
临床试验/NL-OMON25283
NL-OMON25283已完成不适用

Screening for brain metastasis in patients with stage III Non-Small Cell Lung Cancer: Has Magnetic Resonance Imaging an additive value compared to contrast enhanced Computed Tomography of the brain Incorporated in the staging whole body 18FDG-PET-CT scanning?

MUMC+0 个研究点目标入组 118 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
118

研究概览

简要总结

Schoenmaekers, J., Hendriks, L. E., Hofman, P. et al, JTO 2016; 12:S1:MA06.05

Schoenmaekers et al, 1365PD - Screening for brain metastases (BM) in patients (pts) with stage III non-small cell lung cancer (NSCLC), magnetic resonance imaging (MRI) or dedicated contrast-enhanced computed tomography (dCE-CT)? A prospective observational study

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Pathology proven NSCLC;
  • 2. UICC stage III;

排除标准

  • 1. Other malignancy that is not controlled or that was diagnosed less than 2 years before enrolment in this study, except skin cancer or cervical cancer in situ;
  • 2. Contra-indication for MRI or CE-CT;

研究者

发起方
MUMC+

相似试验